P38 MAPK inhibitors suppress biomarkers of hypertension end-organ damage, osteopontin and plasminogen activator inhibitor-1.

Source:http://linkedlifedata.com/resource/pubmed/id/17438656

Download in:

View as

General Info

PMID
17438656